Page results
-
The UCLH@Home service is helping patients like 55-year-old Sherena Kranat to continue their recovery in their own home under the care of their hospital team.
-
All medications given to you while you are an inpatient are provided free of charge. At follow-up appointments, you may be given a prescription by your doctor or nurse. This must be collected from the hospital pharmacy; you cannot take it to your local chemist. There is a standard prescription charge per item which you can pay for by cash or card.
-
This is an 8-week online parent group led by the Child Wellbeing Practitioners at UCLH.
-
A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.
-
In the UK in 2020, 23 million Novo Nordisk FlexPen and FlexTouch pre-filled devices were incinerated or sent to landfill as there was no viable recycling alternative.
-
We have been informed that there has been an increasing number of fractures in the battery securing parts of this pump. During the insulin pump use, if the device is dropped or excessive force is applied, some of the device's battery securing parts may break.
-
Until this point, if a largely over estimated total daily dose was entered by the user incorrectly, there is a risk of over delivery of insulin during Auto mode. This risk is the highest on the first day and reduces gradually over subsequent days.
-
UCLH is reminding staff that gloves are not always required, by reducing the instances where non-sterile plastic gloves are used when treating non-infectious patients. The focus is now on how clean hands are just as effective a barrier against infection.
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
Our arrhythmia service is designed to treat patients with all types of heart rhythm problems.
File results
-
FOI/2021/0696 - Procurement of Robotic Process Automation (RPA)
-
FOI/2021/0704 - Language translation and interpreting services
-
FOI/2021/0708 - Treatment of dermatological conditions
-
FOI/2021/0713 - Incidence and treatment of Haemophilia A
-
FOI/2021/0714 - Data management systems of care testing devices
-
FOI/2021/0715 - Urothelial cancer treatment
-
FOI/2021/0716 - COVID-19 deaths
-
FOI/2021/0721 - Maternity units within your trust
-
FOI/2021/0723 - Covid 19 deaths
-
FOI/2021/0730 - Treatment with Ofatumumab